The FDA has approved a self-expanding peripheral stent system (EverFlex, ev3) for use in re-opening stenotic regions in the superficial femoral and proximal popliteal arteries. The stent system is designed to restore blood flow to the legs of patients with atherosclerosis.
Source: FDA
